These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 12235811)
1. [Analysis of mouse model exhibiting neurofibrillary changes]. Takashima A Rinsho Shinkeigaku; 2001 Dec; 41(12):1111-2. PubMed ID: 12235811 [TBL] [Abstract][Full Text] [Related]
2. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. Tanemura K; Akagi T; Murayama M; Kikuchi N; Murayama O; Hashikawa T; Yoshiike Y; Park JM; Matsuda K; Nakao S; Sun X; Sato S; Yamaguchi H; Takashima A Neurobiol Dis; 2001 Dec; 8(6):1036-45. PubMed ID: 11741399 [TBL] [Abstract][Full Text] [Related]
3. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
4. Transgenic zebrafish model of neurodegeneration. Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595 [TBL] [Abstract][Full Text] [Related]
5. Divergent phosphorylation pattern of tau in P301L tau transgenic mice. Deters N; Ittner LM; Götz J Eur J Neurosci; 2008 Jul; 28(1):137-47. PubMed ID: 18662339 [TBL] [Abstract][Full Text] [Related]
6. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192 [TBL] [Abstract][Full Text] [Related]
7. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182 [TBL] [Abstract][Full Text] [Related]
8. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice. Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886 [TBL] [Abstract][Full Text] [Related]
9. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474 [TBL] [Abstract][Full Text] [Related]
10. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models. Zhang Q; Zhang X; Sun A Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923 [TBL] [Abstract][Full Text] [Related]
11. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621 [TBL] [Abstract][Full Text] [Related]
12. Impairments in impulse control in mice transgenic for the human FTDP-17 tauV337M mutation are exacerbated by age. Lambourne SL; Humby T; Isles AR; Emson PC; Spillantini MG; Wilkinson LS Hum Mol Genet; 2007 Jul; 16(14):1708-19. PubMed ID: 17517691 [TBL] [Abstract][Full Text] [Related]
13. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease. Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433 [TBL] [Abstract][Full Text] [Related]
15. [Significance of tau in the development of Alzheimer's disease]. Takashima A Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874 [TBL] [Abstract][Full Text] [Related]
16. Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation. Taniguchi T; Doe N; Matsuyama S; Kitamura Y; Mori H; Saito N; Tanaka C FEBS Lett; 2005 Oct; 579(25):5704-12. PubMed ID: 16219306 [TBL] [Abstract][Full Text] [Related]
17. Tau in aluminum-induced neurofibrillary tangles. Singer SM; Chambers CB; Newfry GA; Norlund MA; Muma NA Neurotoxicology; 1997; 18(1):63-76. PubMed ID: 9215989 [TBL] [Abstract][Full Text] [Related]
18. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease. Treiber-Held S; Distl R; Meske V; Albert F; Ohm TG J Pathol; 2003 May; 200(1):95-103. PubMed ID: 12692847 [TBL] [Abstract][Full Text] [Related]
19. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]